对爱斯坦-巴尔病毒相关疾病的诊断算法的开发:一项回顾性观察性研究
Jiaoyuan Li1, Hongyan Hou1, Juan Song2
1Department of Laboratory Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Journal of medical virology
|May 28, 2025
概括
血和PBMC中的爱斯坦-巴尔病毒 (EBV) DNA在患有EBV相关疾病的患者中高度可检测. 建议使用血EBVDNA测试作为高风险个体的第一线诊断方法.
科学领域:
- 病毒学 病毒学
- 传染性疾病 传染性疾病
- 分子诊断学 分子诊断学
背景情况:
- 爱斯坦-巴尔病毒 (EBV) 与各种人类疾病有关.
- 准确诊断和区分EBV相关疾病对于有效管理至关重要.
- 了解EBV在不同疾病背景中的分子和血清特征至关重要.
研究的目的:
- 研究中国EBV相关疾病的分子和血清特征.
- 为了在不同与EBV相关的疾病中比较EBV DNA水平和抗体概况.
- 评估血和外围血液单核细胞 (PBMC) EBV DNA检测的诊断效用.
主要方法:
- 一个多中心的回顾性队列研究,涉及746名患有EBV相关疾病的患者和350名对照.
- 定量聚合酶连锁反应 (qPCR) 用于在血和PBMC中量化EBV DNA.
- 化学发光免疫测试用于检测四种EBV特异性抗体 (VCA-IgM,EBNA-IgG).
主要成果:
- 在患者的PBMC (97.7%) 和血 (92.6%) 中观察到高的EBV DNA阳性率,明显高于对照组.
- 在PBMC中EBVDNA阳性在大多数疾病中几乎是普遍的,除了鼻癌 (87.4%).
- 血EBVDNA阳性因疾病而异,而大多数组显示病毒体抗原IgM低,EBV核抗原IgG高,除传染性单核病外.
结论:
- 血中的EBV DNA是区分EBV相关疾病与对照病的有价值标记,PBMC EBV DNA提高了诊断准确度.
- 在不同与EBV相关的疾病中,EBV DNA和抗体反应存在不同的模式.
- 建议作为主要诊断工具进行血EBVDNA测试,如果血结果为阴性,则进行PBMC测试,并进行全面的血清学评估.
相关概念视频
Steps in Outbreak Investigation
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
Investigation of Disease Outbreaks
Multistate foodborne outbreaks pose significant public health risks and require meticulous investigation to identify sources and implement control measures. The Centers for Disease Control and Prevention (CDC) utilizes a dynamic seven-step process for these investigations, integrating data from laboratories, interviews, and environmental assessments to protect public health.Outbreak Detection: The detection of multistate outbreaks typically begins with PulseNet, the CDC's national laboratory...


